Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
暂无分享,去创建一个
[1] G. Clover,et al. The effect of age on the macromolecular permeability of human Bruch's membrane. , 2001, Investigative ophthalmology & visual science.
[2] Peter M. G. Munro,et al. Collagen VI assemblies in age-related macular degeneration. , 2002, Journal of structural biology.
[3] W R Green,et al. Pathologic Features of Senile Macular Degeneration , 1985, Ophthalmology.
[4] N. Bressler,et al. Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans. , 1998, American journal of ophthalmology.
[5] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[6] M. Walport,et al. Complement. Second of two parts. , 2001, The New England journal of medicine.
[7] N. Takami,et al. Involvement of intracellular cyclic GMP and cyclic GMP-dependent protein kinase in alpha-elastin-induced macrophage chemotaxis. , 1997, Journal of biochemistry.
[8] Paul Mitchell,et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.
[9] M. Klein,et al. Heredity and age-related macular degeneration. Observations in monozygotic twins. , 1994, Archives of ophthalmology.
[10] M. Klein,et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. , 2003, Human molecular genetics.
[11] C. Curcio,et al. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. , 2005, Investigative ophthalmology & visual science.
[12] C. Curcio,et al. Photoreceptor loss in age-related macular degeneration. , 1996, Investigative ophthalmology & visual science.
[13] Jian Ge,et al. CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD , 2005, PLoS medicine.
[14] L. V. Johnson,et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.
[15] Neil M Bressler,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.
[16] M. Jackson,et al. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome , 2006, Human mutation.
[17] Shigeo Yoshida,et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. , 2004, American journal of human genetics.
[18] P. Mitchell,et al. Smoking and age-related macular degeneration: a review of association , 2005, Eye.
[19] M. Killingsworth,et al. Evolution of soft drusen in age-related macular degeneration , 1994, Eye.
[20] J. J. Wang,et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.
[21] S. Russell,et al. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. , 2000, American journal of ophthalmology.
[22] J. J. Wang,et al. The prevalence of age-related maculopathy: the visual impairment project. , 2000, Ophthalmology.
[23] J. Sorenson,et al. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. , 2005, Ophthalmology.
[24] Don H. Anderson,et al. Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. , 2005, Investigative ophthalmology & visual science.
[25] J. Marshall,et al. Age-related variation in the hydraulic conductivity of Bruch's membrane. , 1995, Investigative ophthalmology & visual science.
[26] T. Matise,et al. Age-related macular degeneration--a genome scan in extended families. , 2003, American journal of human genetics.
[27] J. Vander,et al. The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No 17 , 2006 .
[28] R. Klein,et al. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. , 2005, Archives of ophthalmology.
[29] Philip J Rosenfeld,et al. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. , 2005, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[30] T. Peto,et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. , 2003, Ophthalmology.
[31] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[32] John Michael. Age-Related Macular Degeneration: Principles and Practice , 1994 .
[33] J. Neitz,et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. , 2001, American journal of ophthalmology.
[34] P. Ridker,et al. Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. , 2006, Atherosclerosis.
[35] Robert F Mullins,et al. Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. , 2005, The American journal of pathology.
[36] M. Kamei,et al. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.
[37] R C Kleiner,et al. Contrast sensitivity in age-related macular degeneration. , 1988, Archives of ophthalmology.
[38] N. Bressler. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. , 2001 .
[39] A. Cideciyan,et al. Dominant late-onset retinal degeneration with regional variation of sub-retinal pigment epithelium deposits, retinal function, and photoreceptor degeneration. , 2000, Ophthalmology.
[40] J. Lambris,et al. Complement: an inflammatory pathway fulfilling multiple roles at the interface of innate immunity and development. , 2005, Current drug targets. Inflammation and allergy.
[41] B S Hawkins,et al. Epidemiology of age-related macular degeneration. , 1999, Molecular vision.
[42] Alexander J. Rivest,et al. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[43] Cynthia Owsley,et al. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy , 2002, Ageing Research Reviews.
[44] A. Mizota,et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. , 2006, Molecular vision.
[45] C. Curcio,et al. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. , 2005, Experimental eye research.
[46] Hans Lassmann,et al. Recent neuropathological findings in MS—implications for diagnosis and therapy , 2004, Journal of Neurology.
[47] Alexander J. Rivest,et al. Characterization of Beta Amyloid-containing Vesicles within Drusen , 2003 .
[48] A Hofman,et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.
[49] T. Halstensen,et al. Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon. , 1989, Gut.
[50] Alston Callahan,et al. The role of inflammation in the pathogenesis of age-related macular degeneration. , 2006, Survey of ophthalmology.
[51] A. Ho,et al. RISK FACTORS FOR CHOROIDAL NEOVASCULARIZATION AND VISION LOSS IN THE FELLOW EYE STUDY OF CNVPT , 2003, Retina.
[52] J. Haines,et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. , 2006, American journal of human genetics.
[53] H. Taylor,et al. Vision loss in Australia , 2005, The Medical journal of Australia.
[54] S. Wray,et al. Menkes' kinky hair disease: a light and electron microscopic study of the eye. , 1976, Investigative ophthalmology.
[55] J. Féher,et al. [On the structure of Bruch's membrane]. , 1967, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology.
[56] J. Alvarado,et al. Studies on the human macula. IV. Aging changes in Bruch's membrane. , 1967, Archives of ophthalmology.
[57] S. Horiuchi,et al. Advanced glycation end products in age-related macular degeneration. , 1998, Archives of ophthalmology.
[58] S. Meri,et al. Molecular Mechanisms of Target Recognition in an Innate Immune System: Interactions Among Factor H, C3b, and Target in the Alternative Pathway of Human Complement1 2 , 2000, The Journal of Immunology.
[59] R. Guymer,et al. Changes in Bruch’s membrane and related structures with age , 1999, Progress in Retinal and Eye Research.
[60] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[61] M. Killingsworth,et al. Macrophages related to Bruch's membrane in age-related macular degeneration , 1990, Eye.
[62] J. Lupski,et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. , 1997, Science.
[63] T. Friberg. The Prophylactic Treatment of AMD Multi–Centered Trial (PTAMD): Results From the Bilateral Study Arm , 2006 .
[64] Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.
[65] C Owsley,et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.
[66] J. Marshall,et al. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. , 1996, Experimental eye research.
[67] N. Bressler,et al. Translocation of the Retina for Management of Subfoveal Choroidal Neovascularization II: A Preliminary Report in Humans , 1999 .
[68] K. Niemi,et al. OCULAR FINDINGS IN FOUR SIBLINGS WITH PSEUDOXANTHOMA ELASTICUM , 1983, Acta ophthalmologica.
[69] E. Midena,et al. Macular drusen and the sensitivity of the central visual field , 2005, Documenta Ophthalmologica.
[70] R. Klein,et al. Sibling correlations and segregation analysis of age‐related maculopathy: The beaver dam eye study , 1994, Genetic epidemiology.
[71] M. Blumenkranz,et al. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. , 2002, Archives of ophthalmology.
[72] Umberto Boffa,et al. Vision loss in Australia , 2005, The Medical journal of Australia.
[73] Irina Klimanskaya,et al. Retinal pigment epithelium. , 2006, Methods in enzymology.
[74] R. Machemer,et al. Retinal separation, retinotomy, and macular relocation II. A surgical approach for age-related macular degeneration? , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.
[75] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[76] S. Barnum,et al. Local production of complement proteins in rheumatoid arthritis synovium. , 2002, Arthritis and rheumatism.
[77] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[78] A. Hofman,et al. Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. , 2000, Investigative ophthalmology & visual science.
[79] G. Hageman,et al. Characterization of drusen-associated glycoconjugates. , 1997, Ophthalmology.
[80] D A Newsome,et al. Analysis of newly synthesized Bruch's membrane proteoglycans. , 1989, Investigative ophthalmology & visual science.
[81] Harold Snieder,et al. Genetic influence on early age-related maculopathy: a twin study. , 2002, Ophthalmology.
[82] J S Sunness,et al. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. , 1999, Molecular vision.
[83] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[84] P T de Jong,et al. Analysis of carbohydrate structures in basal laminar deposit in aging human maculae. , 1994, Investigative ophthalmology & visual science.
[85] S. Russell,et al. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[86] J. Atkinson,et al. Hemolytic Uremic Syndrome: An Example of Insufficient Complement Regulation on Self‐Tissue , 2005, Annals of the New York Academy of Sciences.
[87] M. Hogan. Role of the retinal pigment epithelium in macular disease. , 1972, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.
[88] John D Lambris,et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. , 2005, Journal of the American Society of Nephrology : JASN.
[89] Andreas Persidis,et al. Novel biological networks modulated by complement. , 2005, Clinical immunology.
[90] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[91] Johannes R. Vingerling,et al. The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.
[92] F. Topouzis,et al. Contrast sensitivity evaluation in eyes predisposed to age-related macular degeneration and presenting normal visual acuity. , 1995, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[93] Nis Andersen. Age-related macular degeneration among the Inuit in Greenland. , 2004, International journal of circumpolar health.
[94] S. Sivaprasad,et al. Bruch's membrane and the vascular intima: is there a common basis for age‐related changes and disease? , 2005, Clinical & experimental ophthalmology.
[95] Thomas D. Koepsell,et al. Visual impairment and cognitive dysfunction in Alzheimer’s disease , 1991, Journal of General Internal Medicine.
[96] Alexander J. Rivest,et al. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. , 2004, Experimental eye research.
[97] Wiklund Ra,et al. First of two parts , 1997 .
[98] N. Bressler,et al. Persistent and recurrent neovascularization after krypton laser kphotocoagualation for neovascular lesions fo age-related macular degenration , 1990 .
[99] Geoffrey P Lewis,et al. Drusen-associated degeneration in the retina. , 2003, Investigative ophthalmology & visual science.
[100] A. Bird,et al. Aging changes in Bruch's membrane. A histochemical and morphologic study. , 1990, Ophthalmology.
[101] S M Meyers,et al. A twin study of age-related macular degeneration. , 1995, American journal of ophthalmology.
[102] A. Bird,et al. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. , 1994, Archives of ophthalmology.
[103] T. Matise,et al. Age-related Macular Degeneration: A Genome-wide Scan in Extended Families , 2003 .
[104] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[105] H. Brodaty,et al. Psychosocial effects of age-related macular degeneration. , 2007, International psychogeriatrics.
[106] Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.
[107] P. Luthert,et al. Decreased Thickness and Integrity of the Macular Elastic Layer of Bruch's Membrane Correspond to the , 2005 .
[108] M. Boulton,et al. RPE lipofuscin and its role in retinal pathobiology. , 2005, Experimental eye research.
[109] C. Gerard,et al. Complement in allergy and asthma. , 2002, Current opinion in immunology.
[110] D. Weeks,et al. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. , 2001, American journal of ophthalmology.
[111] S. Schwartz,et al. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide. , 2006, American journal of ophthalmology.
[112] L. Yannuzzi,et al. Age-related macular degeneration and choroidal neovascularization. , 1993, American journal of ophthalmology.
[113] M. Boulton,et al. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. , 1995, The Journal of biological chemistry.
[114] M. Gillies,et al. Immunological and Aetiological Aspects of Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[115] J. Provis,et al. Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration , 2005, Clinical & experimental optometry.
[116] D. Clayton,et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. , 2006, Investigative ophthalmology & visual science.
[117] W R Green,et al. Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.
[118] J. Fehér,et al. Zur Struktur der Bruchschen Membran , 1967, Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie.
[119] M. Katz,et al. Age-related changes in the retinal pigment epithelium of pigmented rats. , 1984, Experimental eye research.
[120] D. Archer,et al. The histochemistry of drusen. , 1971, American journal of ophthalmology.
[121] D. Weeks,et al. A full genome scan for age-related maculopathy. , 2000, Human molecular genetics.
[122] D. Weeks,et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.
[123] G. Hageman,et al. Molecular composition of drusen as related to substructural phenotype. , 1999, Molecular vision.
[124] J. Thurman,et al. The alternative pathway of complement in disease: opportunities for therapeutic targeting. , 2004, Molecular immunology.
[125] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[126] G. R. Jackson,et al. Impact of aging and age-related maculopathy on activation of the a-wave of the rod-mediated electroretinogram. , 2004, Investigative ophthalmology & visual science.
[127] A. Bird,et al. [Biochemical and histochemical analysis of age related lipid deposits in Bruch's membrane]. , 1994, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[128] Jurg Ott,et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.
[129] D. Easty,et al. Preparation of Bruch's membrane and analysis of the age-related changes in the structural collagens. , 1995, The British journal of ophthalmology.
[130] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[131] V. Holers,et al. The complement system as a therapeutic target in autoimmunity. , 2003, Clinical immunology.
[132] U. Schmidt-Erfurth,et al. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. , 2000, Survey of ophthalmology.
[133] Joan W. Miller,et al. Randomized, Controlled Phase III Study of Ranibizumab (LucentisTM) for Minimally Classic or Occult Neovascular Age–Related Macular Degeneration: Two–Year Efficacy Results of the MARINA Study , 2006 .
[134] Mary A. Johnson,et al. Diminished foveal sensitivity may predict the development of advanced age-related macular degeneration. , 1989, Ophthalmology.
[135] M. Tso,et al. Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration , 2001, The British journal of ophthalmology.
[136] R. Avery,et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. , 2006, Ophthalmology.
[137] A C Bird,et al. Bruch's membrane change with age. , 1992, The British journal of ophthalmology.
[138] A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. , 2003, American journal of human genetics.
[139] Sander R. Dubovy,et al. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. , 2004, American journal of ophthalmology.
[140] D. Weeks,et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. , 2005, Human molecular genetics.
[141] G. Abecasis,et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.
[142] A. Abyad. In-office screening for age-related hearing and vision loss. , 1997, Geriatrics.
[143] C Bellman,et al. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. , 2001, Investigative ophthalmology & visual science.
[144] G. Nackman,et al. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. , 1997, Surgery.
[145] W. Heriot,et al. Choroidal neovascularization can digest Bruch's membrane. A prior break is not essential. , 1984, Ophthalmology.
[146] J. Slakter,et al. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. , 2003, Ophthalmology.
[147] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[148] Ronald Klein,et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.
[149] J. Folk,et al. Visual loss after successful photocoagulation of choroidal neovascularization. , 1988, Ophthalmology.
[150] T. Peto,et al. Zinc in Drusen , 2005 .
[151] K. Lai,et al. Pathogenesis of lupus nephritis: An update , 2005, Nephrology.
[152] P. D. de Jong,et al. Morphologic changes in age‐related maculopathy , 1997, Microscopy research and technique.
[153] Johanna M Seddon,et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.
[154] S. A. Vinores. Anecortave (Alcon Laboratories). , 2005, IDrugs : the investigational drugs journal.
[155] N. Bressler,et al. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.
[156] P T de Jong,et al. Is basal laminar deposit unique for age-related macular degeneration? , 1991, Archives of ophthalmology.
[157] J. Marshall,et al. Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. , 2002, Journal of the Optical Society of America. A, Optics, image science, and vision.
[158] J. Haines,et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. , 2004, American journal of human genetics.
[159] R. Guymer,et al. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? , 2005, Survey of ophthalmology.
[160] A. Buil,et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. , 2005, Human molecular genetics.
[161] Marco A Zarbin,et al. Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.
[162] F. Gibbs,et al. Radiotherapy for age-related macular degeneration: no more pilot studies please , 2005, Eye.
[163] P. Zipfel,et al. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. , 2006, Molecular immunology.
[164] W. Lee,et al. Basal linear deposit in the human macula , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[165] Lars G Fritsche,et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. , 2005, Human molecular genetics.
[166] Wen-chao Song,et al. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury. , 2004, Current directions in autoimmunity.
[167] M. Lokki,et al. Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes , 2004, Immunogenetics.
[168] W. Green,et al. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. , 1994, Archives of ophthalmology.
[169] L. Feeney-Burns,et al. Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. , 1984, Investigative ophthalmology & visual science.
[170] M. Maguire,et al. The age-related macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study. , 2004, American journal of ophthalmology.
[171] Alexander J. Rivest,et al. The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[172] J. McNeil,et al. Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. , 2005, American journal of epidemiology.
[173] Jill Carlton,et al. The impact of age-related macular degeneration on health status utility values. , 2005, Investigative ophthalmology & visual science.
[174] T. Matise,et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.
[175] M. Killingsworth,et al. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.
[176] J. Vander. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810-Nanometer Laser to Eyes with Drusen. Unilaterally Eligible PatientsFriberg TR, and the PTAMD Study Group (Univ of Pittsburgh, Pa; et al) Ophthalmology 113:612–622, 2006§ , 2007 .
[177] J. Handa,et al. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. , 1999, Investigative ophthalmology & visual science.
[178] S. Sarks,et al. Ageing and degeneration in the macular region: a clinico-pathological study. , 1976, The British journal of ophthalmology.
[179] A. Eisner,et al. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. , 1991, Investigative ophthalmology & visual science.
[180] E. Gragoudas,et al. Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.
[181] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[182] T. Ishibashi,et al. Aging changes in Bruch's membrane of monkeys: an electron microscopic study. , 1986, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.
[183] A. Eisner,et al. Visual function and the subsequent development of exudative age-related macular degeneration. , 1992, Investigative ophthalmology & visual science.
[184] U Chakravarthy,et al. Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2 , 2005, British Journal of Ophthalmology.
[185] The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology , 2004, Clinical trials.
[186] Matthew D. Davis,et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. , 2005, Archives of ophthalmology.
[187] K. Yaffe,et al. Vision Impairment and Combined Vision and Hearing Impairment Predict Cognitive and Functional Decline in Older Women , 2002, Journal of the American Geriatrics Society.
[188] A. Bird,et al. Long-term drusen study. , 1999, Retina.
[189] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[190] Cynthia Owsley,et al. Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. , 2006, Investigative ophthalmology & visual science.
[191] P T de Jong,et al. Histologic features of the early stages of age-related macular degeneration. A statistical analysis. , 1992, Ophthalmology.
[192] Simon P. Harding,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. , 2001, American journal of ophthalmology.
[193] P. Zipfel. Complement Factor H: Physiology and Pathophysiology , 2001, Seminars in thrombosis and hemostasis.
[194] S. Resnikoff,et al. Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.
[195] G. Abecasis,et al. Meta-analysis of genome scans of age-related macular degeneration. , 2005, Human molecular genetics.
[196] Nis Andersen,et al. Age-related macular degeneration in Inuit in Greenland , 2004 .
[197] Cynthia Owsley,et al. Visual dysfunction, neurodegenerative diseases, and aging. , 2003, Neurologic clinics.
[198] Hans E. Grossniklaus,et al. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. , 1997 .
[199] T. Freddo,et al. The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing light microscopy. , 2001, Investigative ophthalmology & visual science.
[200] G. Hageman,et al. Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.
[201] J. Goodship,et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. , 1998, Kidney international.
[202] J. Weiter,et al. Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. , 1989, Investigative ophthalmology & visual science.
[203] V. Sheffield,et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.
[204] M. Ellersieck,et al. Age-related changes in the ultrastructure of Bruch's membrane. , 1985, American journal of ophthalmology.
[205] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[206] N. Bressler. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.
[207] C. Curcio,et al. Accumulation of cholesterol with age in human Bruch's membrane. , 2001, Investigative ophthalmology & visual science.
[208] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[209] T. Wong,et al. The epidemiology of age related eye diseases in Asia , 2006, British Journal of Ophthalmology.
[210] P T de Jong,et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.
[211] Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group. , 1986, Archives of ophthalmology.
[212] B. Rovner,et al. Effect of depression on vision function in age-related macular degeneration. , 2002, Archives of ophthalmology.
[213] P. deJong,et al. CNV subtype in first eyes predicts severity of ARM in fellow eyes , 2003, The British journal of ophthalmology.
[214] T. Das,et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. , 2005, Investigative ophthalmology & visual science.
[215] A. Munnich,et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. , 1998, American journal of ophthalmology.
[216] W. Green,et al. Bruch's membrane age-related changes vary by region. , 1987, Current eye research.
[217] George A. Williams,et al. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. , 1999, Controlled clinical trials.
[218] Robyn H Guymer,et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. , 2004, Investigative ophthalmology & visual science.
[219] M. Sandberg,et al. SLOW PHOTOSTRESS RECOVERY AND DISEASE SEVERITY IN AGE‐RELATED MACULAR DEGENERATION , 1995, Retina.
[220] A C Bird,et al. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. , 1999, Investigative ophthalmology & visual science.
[221] H. Cook,et al. Complement and glomerulonephritis: new insights , 2005, Current opinion in nephrology and hypertension.
[222] P. Jong,et al. Immunohistochemical light and electron microscopy of basal laminar deposit , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[223] P. Zipfel,et al. Complement Factor H Is a Serum-binding Protein for Adrenomedullin, and the Resulting Complex Modulates the Bioactivities of Both Partners* , 2001, The Journal of Biological Chemistry.
[224] M. Katz. Potential role of retinal pigment epithelial lipofuscin accumulation in age-related macular degeneration. , 2002, Archives of gerontology and geriatrics.
[225] P. Zipfel,et al. An interactive web database of factor H‐associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease‐associated mutations , 2006, Human mutation.
[226] Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. , 2004, American journal of human genetics.
[227] C. Curcio,et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. , 2003, The American journal of pathology.
[228] H. Grossniklaus,et al. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. , 1996, Investigative ophthalmology & visual science.
[229] A. Munnich,et al. The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration , 1998 .
[230] Alexander J. Rivest,et al. Characterization of β amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration , 2004 .
[231] G. Remuzzi,et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. , 2006, Blood.
[232] G. R. Jackson,et al. Delays in rod-mediated dark adaptation in early age-related maculopathy. , 2001, Ophthalmology.
[233] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[234] Matthew A. Thomas,et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. , 2004, Ophthalmology.
[235] David J. Wilson,et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. , 2004, Ophthalmology.
[236] S. Santangelo,et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. , 2003, American journal of human genetics.
[237] D. S. Mcleod,et al. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. , 2002, Investigative ophthalmology & visual science.
[238] J L McRae,et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.
[239] P. Penfold,et al. An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. , 1984, Australian journal of ophthalmology.
[240] E. Souied,et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. , 2005, Molecular vision.
[241] J. Thurman,et al. The Central Role of the Alternative Complement Pathway in Human Disease1 , 2006, The Journal of Immunology.
[242] M. C. Leske,et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. , 2006, Ophthalmology.
[243] J. Jonas,et al. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. , 2006, American journal of ophthalmology.
[244] G. Remuzzi,et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. , 2003, Human molecular genetics.
[245] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[246] J. Gilbert,et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. , 2006, Investigative ophthalmology & visual science.
[247] A. Hofman,et al. Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.
[248] S. Rodríguez de Córdoba,et al. The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.
[249] C. Grindle,et al. Ageing changes in Bruch's membrane and their functional implications. , 1978, Transactions of the ophthalmological societies of the United Kingdom.
[250] M. Killingsworth,et al. Softening of drusen and subretinal neovascularization. , 1980, Transactions of the ophthalmological societies of the United Kingdom.
[251] R. Locksley,et al. The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.